Total Payments
$502.94
2024 Payments
$137.50
Companies
3
Transactions
27
Medicare Patients
2,022
Medicare Billing
$158,255
Payment Breakdown by Category
Food & Beverage$502.94 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $502.94 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $347.23 | 25 | $0 (2022) |
| Penumbra, Inc. | $137.50 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $18.21 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.50 | 1 | Penumbra, Inc. ($137.50) |
| 2022 | $105.58 | 6 | Merck Sharp & Dohme LLC ($105.58) |
| 2021 | $34.14 | 2 | Merck Sharp & Dohme Corporation ($34.14) |
| 2020 | $34.12 | 2 | Janssen Pharmaceuticals, Inc ($18.21) |
| 2019 | $54.93 | 4 | Merck Sharp & Dohme Corporation ($54.93) |
| 2018 | $76.49 | 7 | Merck Sharp & Dohme Corporation ($76.49) |
| 2017 | $60.18 | 5 | Merck Sharp & Dohme Corporation ($60.18) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $137.50 | General |
| Category: Peripheral Intervention | ||||||
| 12/12/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: ONCOLOGY | ||||||
| 04/14/2022 | Merck Sharp & Dohme LLC | REBLOZYL (Biological) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: HEMATOLOGY | ||||||
| 04/13/2022 | Merck Sharp & Dohme LLC | REBLOZYL (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: HEMATOLOGY | ||||||
| 04/06/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: ONCOLOGY | ||||||
| 06/15/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/03/2019 | Merck Sharp & Dohme Corporation | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2019 | Merck Sharp & Dohme Corporation | LENVIMA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2019 | Merck Sharp & Dohme Corporation | LENVIMA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: ONCOLOGY | ||||||
| 08/24/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LENVIMA | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: ONCOLOGY | ||||||
| 03/23/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: ONCOLOGY | ||||||
| 11/28/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: ONCOLOGY | ||||||
| 05/10/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $10.34 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 427 | 445 | $190,547 | $32,760 |
| 2022 | 5 | 446 | 470 | $246,859 | $33,098 |
| 2021 | 5 | 439 | 456 | $185,119 | $35,330 |
| 2020 | 5 | 710 | 751 | $310,851 | $57,067 |
Total Patients
2,022
Total Services
2,122
Medicare Billing
$158,255
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 121 | 122 | $93,032 | $15,914 | 17.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 113 | 117 | $60,740 | $10,538 | 17.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 20 | $17,049 | $2,976 | 17.5% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 45 | 47 | $14,445 | $2,493 | 17.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 128 | 139 | $5,281 | $839.34 | 15.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 145 | 150 | $74,314 | $13,832 | 18.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 82 | 87 | $135,253 | $12,195 | 9.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 65 | 65 | $19,977 | $3,538 | 17.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 16 | $11,619 | $2,602 | 22.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 138 | 152 | $5,696 | $931.50 | 16.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 101 | 103 | $79,710 | $14,872 | 18.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 118 | 119 | $60,149 | $11,286 | 18.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 25 | 26 | $19,347 | $4,666 | 24.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 67 | 67 | $20,593 | $3,609 | 17.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 128 | 141 | $5,320 | $896.47 | 16.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 199 | 205 | $144,249 | $27,222 | 18.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 196 | 210 | $103,068 | $18,073 | 17.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 36 | 38 | $29,112 | $6,565 | 22.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 88 | 90 | $27,351 | $3,841 | 14.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 191 | 208 | $7,071 | $1,365 | 19.3% |
About Dr. James Herrington, D.O
Dr. James Herrington, D.O is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1356603674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Herrington, D.O has received a total of $502.94 in payments from pharmaceutical and medical device companies, with $137.50 received in 2024. These payments were reported across 27 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($502.94).
As a Medicare-enrolled provider, Herrington has provided services to 2,022 Medicare beneficiaries, totaling 2,122 services with total Medicare billing of $158,255. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Tulsa, OK
- Active Since 06/12/2012
- Last Updated 12/16/2016
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356603674
Products in Payments
- KEYTRUDA (Biological) $226.20
- Indigo System (Device) $137.50
- EMEND (Drug) $34.32
- REBLOZYL (Biological) $32.86
- LENVIMA (Drug) $29.32
- XARELTO (Drug) $18.21
- LYNPARZA (Biological) $14.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Emergency Medicine $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Emergency Medicine $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
Emergency Medicine $5,156
Trung Pham, D.o, D.O
Emergency Medicine — Payments: $3,718
Emergency Medicine $3,718
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Emergency Medicine $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507
Emergency Medicine $1,507